Subsets of CTCs expressing cell surface markers such as CD90 [11,12], EpCAM [13], CD133 [12], and vimentin [12] have been associated with cancer stemness and epithelial–mesenchymal transition (EMT), and reports on these subsets are increasing. Here, THY1 is linked to cancer.